怀疑神经认知障碍的老年犯罪者:一项探索性研究
Sigfried Schouws1, Naomi Prent2, Frank Jonker3
1GGZ inGeest, Department of Old Age Psychiatry, Amsterdam, the Netherlands.
Criminal behaviour and mental health : CBMH
|January 8, 2026
概括
认知障碍在老年犯罪者中很常见,与不同犯罪类型相关的不同神经认知群体. 综合性认知评估对于管理风险和确保对这个不断增长的人口给予公平待遇至关重要.
科学领域:
- 法医精神病学 法医精神病学
- 老年学是指老年学的学科.
- 神经心理学 神经心理学
背景情况:
- 全球预期寿命正在增加,导致惩教设施中老年人口的增加.
- 对老年犯罪者的研究有限,尽管潜在的认知障碍会影响行为和治疗反应.
- 老年犯罪者的认知缺陷可能会影响刑事责任和康复策略.
研究的目的:
- 研究60岁及以上罪犯的认知变量,神经诊断和犯罪类型之间的关系.
- 探索面临严重刑事指控的老年人的神经认知特征.
- 了解认知状态如何影响老年人的犯罪模式.
主要方法:
- 对60岁以上成年被告的法医精神病学评估的回顾性分析.
- 包括81个人 (7名女性) 被指控犯下严重罪行.
- 同质性分析 (HOMALS) 根据认知和犯罪数据对参与者进行分类.
主要成果:
- 大约三分之二的老年犯罪者表现出某种形式的认知障碍.
- 确定了三个神经认知组:显著损伤 (通常是痴呆症),中度损伤和最小的/没有损伤.
- 具有显著认知缺陷的老年人更有可能面临暴力指控;中度障碍与暴力和性犯罪相关.
结论:
- 这项研究强调了老年犯罪者的认知障碍的普遍性及其与犯罪类型的关联.
- 彻底的认知评估对于司法系统中老年人的福祉和有效的风险管理至关重要.
- 建议与更大,多样化的队伍进行进一步的研究,以加深对老龄人口认知问题和犯罪的理解.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
33.7K
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.6K
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:30Cognitive Development During Adulthood
768
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
768
01:30Dementia
511
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
511
01:22Alzheimer's Disease: Treatment
806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
544
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
544